Acceptability of randomisation and of withdrawal of ICS therapy among participants
| Acceptability assessment questions | Strongly agree | Agree | Disagree | Strongly disagree | Not available |
| All participants | |||||
| I was pleased to have a COPD check as part of the trial (n=37) | 30 (81%) | 7 (19%) | 0 | 0 | 0 |
| Allocation at random at the start of the trial to continue or to stop my steroid inhaler was acceptable to me (n=38) | 29 (76%) | 9 (24%) | 0 | 0 | 0 |
| I found the tests (blood test, breathing test, questionnaires) at each appointment acceptable (n=38) | 28 (74%) | 10 (26%) | 0 | 0 | 0 |
| Taking part in this research took up too much of my time (n=38) | 0 | 0 | 0 | 24 (63%) | 14 (37%) |
| ICS withdrawal participants only | |||||
| I understand the reasons why this trial is being done (n=19) | 9 (47%) | 10 (53%) | 0 | 0 | 0 |
| The research team answered my questions satisfactorily (n=19) | 10 (53%) | 9 (47%) | 0 | 0 | 0 |
| The telephone calls from the research team to check how I found the withdrawal of my inhaler were helpful (n=19) | 12 (63%) | 7 (37%) | 0 | 0 | 0 |
| The instructions on how to reduce the dose of my steroid inhaler were clear (n=19) | 10 (53%) | 9 (47%) | 0 | 0 | 0 |
| Stopping my steroid inhaler has made me feel better (n=19) | 3 (16%) | 6 (32%) | 6 (32%) | 3 (16%) | 1 (4%) |
| Stopping my steroid inhaler has made me feel worse (n=19) | 2 (11%) | 5 (26%) | 11 (58%) | 1 (5%) | 0 |
COPD, chronic obstructive pulmonary disease ; ICS, inhaled corticosteroids .